| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $141.8M | +50.2% |
| Cost of Revenue | $27.5M | +54.4% |
| Gross Profit | $114.3M | +49.2% |
| R&D Expense | $13.6M | +33.1% |
| SG&A Expense | $33.0M | +79.0% |
| Operating Income | -$34.8M | -111.0% |
| Interest Expense | $4.4M | +8.3% |
| Income Tax | $0 | — |
| Net Income | -$42.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.5M | -81.6% |
| Short-term Investments | $61.8M | — |
| Accounts Receivable | $29.2M | +57.2% |
| Inventory | $19.3M | +83.0% |
| Current Assets | $133.4M | -3.3% |
| Total Assets | $159.0M | +12.9% |
| Current Liabilities | $30.2M | +66.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.6M | -78.3% |
| Capital Expenditures | $14.8M | +448.5% |
| Investing Cash Flow | -$76.5M | -2728.8% |
| Financing Cash Flow | $20.8M | -80.7% |
| Free Cash Flow | -$45.5M | -128.6% |
| -108.3% |
| EPS (Basic) | -$0.77 | -79.1% |
| EPS (Diluted) | -$0.77 | -79.1% |
| Long-term Debt |
| $52.7M |
| +79.5% |
| Total Liabilities | $98.5M | +106.3% |
| Stockholders' Equity | $60.5M | -35.0% |